BackCore Laboratories Overview
Core Laboratories Inc

Core Laboratories Target Price

Analysts' average 12-month price target for Core Laboratories is $21.

Get informed when a big investor buys or sells

+ Follow

Share Price

$12.39

Average Target Price

$21.0069.5% upside

1 analysts in the last 4 months

High: $21 | Low: $21

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-13Johnson Rice$2169.5% upsideOpen
2024-07-15Piper SandlerLuke Lemoine$1737.2% upsideOpen
2023-02-07Citigroup$26109.8% upsideOpen
2022-05-02Morgan Stanley$32158.3% upsideOpen

Core Laboratories (CLB) FAQ

Core Laboratories (CLB) currently reports a target price of $21. Use the charts on this page to explore Core Laboratories's target price history and peer comparisons.

Analysts' average 12-month price target for Core Laboratories is $21, about 69.5% upside from the current share price of $12.39. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $21, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Core Laboratories, and consider following CLB for alerts when major investors trade the stock.

Core Laboratories is classified in the Energy sector. On target price, it currently shows $21. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Energy are usually more informative than comparing CLB with unrelated industries.